Primary Prevention of Venous Thromboembolism in Long-Term Care: Identifying and Managing the Risk
Authors:
- 1 April 2008
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 14 (2) , 149-158
Abstract
Venous thromboembolism (VTE) is a significant, but underestimated, cause of morbidity and mortality in long-term care settings. VTE risk increases significantly with age and is further increased by comorbidities common to this group; however, advancing age and limited mobility alone are insufficient to warrant pharmacological prophylaxis. Recognizing those at increased VTE risk during an acute illness is crucial for appropriate and timely prophylaxis. Warfarin is used for the long-term secondary prevention of VTE, whereas unfractionated and low-molecular-weight heparins are used for primary prophylaxis. The elderly are at increased risk for bleeding complications, because of the high frequency of comorbidities and comedications. Attention to dosing is recommended for those with severely impaired renal function, low body weight, or perceived to be at high bleeding risk. This review addresses the role of risk assessment in the decision of when to provide prophylaxis to an individual in long-term care and highlights key management issues for those prescribed prophylaxis.Keywords
This publication has 42 references indexed in Scilit:
- Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysisBlood Coagulation & Fibrinolysis, 2007
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Acute pulmonary embolism in elderly: clinical characteristics and outcomeInternational Journal of Cardiology, 2005
- Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsCirculation, 2004
- Challenges in the prevention of venous thromboembolism in the elderlyJournal of Thrombosis and Haemostasis, 2004
- Risk Factors for Deep Vein Thrombosis in Inpatients Aged 65 and Older: A Case‐Control Multicenter StudyJournal of the American Geriatrics Society, 2004
- Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients?Thrombosis and Haemostasis, 2004
- Prevention of venous thromboembolism in medical patients with enoxaparinBlood Coagulation & Fibrinolysis, 2003
- Cost comparison of at‐home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparinInternal Medicine Journal, 2002
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995